⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

January 30, 2026Transfusion and Apheresis Science

A low dose is better than no dose: Is it time to consider lowering the US minimum plateletpheresis yield?

Ludwig Frontier Alyssa Ziman Barbara J. Bryant Manish J. Gandhi RUCHIKA GOEL Jeffrey C. Hebert Tina Ipe Patricia Kopko Kathleen Rowe Roxane Smith Yanyun Wu Richard R. Gammon

View at Publisher

Ask AI

Bookmark

Share

Key Points

Lowering the minimum yield for plateletpheresis may improve blood availability, with implications for patient care.
Current standards for yield are higher than necessary, leading to wasted resources and risks of shortages.
Assessment of existing data indicates that a low dose can be more effective than no dose at all.
Further evaluation is needed to understand the long-term impacts of changing the minimum yield on transfusions.

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Implication

Observational analysis explores lowering the US minimum plateletpheresis yield, suggesting potential benefits for blood transfusion.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Frontier et al. (2026) studied this question.

synapsesocial.com/papers/69a75e98c6e9836116a295cc https://doi.org/10.1016/j.transci.2026.104389

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The argument(s) for lowering the US minimum required content of apheresis platelet componentsMeta-Analysis · 2018 · 24 citations
2Supplemental findings of the 2023 National Blood Collection and Utilization Survey2025 · 10 citations
3Impact of product platelet count reduction on platelet demand in CanadaOriginal Research · 2021 · 3 citations
4Transfusion outcomes between regular and low yield pathogen reduced platelets across different patient populations in a single institutionRetrospective Study · 2022 · 5 citations
5Dose of Prophylactic Platelet Transfusions and Prevention of HemorrhageOriginal Research · 2010 · 666 citations

Prevalence and risk factors of red blood cell alloimmunization among sickle cell disease patients in resource-limited countries: A systematic review and meta-analysisTransfusion and Apheresis Science · 2026
Medical laboratory training in the United StatesTransfusion and Apheresis Science · 2026
Association of initial interface formation time with CD34+ collection efficiency in continuous mononuclear cell collection: A retrospective studyTransfusion and Apheresis Science · 2026
Successful hematopoietic progenitor cell collections using fenestrated peripheral catheters: Safety, performance, and engraftment outcomes in a case seriesTransfusion and Apheresis Science · 2026
Therapeutic plasma exchange and immunomodulatory strategies in post-infectious syndromes: A review of immune dysregulation in PTLDS, long COVID, ME/CFS, and PANS/PANDASTransfusion and Apheresis Science · 2026

More from Transfusion and Apheresis Science

More from Johns Hopkins University

More from University of California, San Diego

More from University of California, Los Angeles

More from University of Miami

More from Mayo Clinic in Arizona

More from Moffitt Cancer Center

More from University of Arkansas for Medical Sciences

More from Canadian Blood Services

More from Vitalant

More from Cerus (United States)

More from Oldham Council

More from Carter BloodCare

More from Macopharma (Germany)